Brain Implants Market cover

Brain Implants Market by Applications (Depression, Essential Tremor, Chronic Pain, Epilepsy, Parkinson’s Disease, and Alzheimer’s Disease), Products (Vagus Nerve Stimulator, Deep Brain Stimulator, and Spinal Cord Stimulator), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

  • Report ID: HC-3556
  • Author: Growth Market Reports
  • Rating: 4.8
  • Total Reviews: 9
  • No. Of Pages: 190
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global brain implants market size was valued at USD 4.5 billion in 2020 and is projected to reach USD 9.05 billion by 2028, expanding at a CAGR of 8.98 % during the forecast period, 2021–2028. The growth of the market is attributed to the increasing awareness regarding brain implant benefits, and positive research outcomes.

Brain Implants Market summary

Brain implants are a type of neural device that is implanted on the surface or cortex of the brain to create a connection between the nervous system and microchips. These implants are intended to aid in the treatment of brain injury. These are developed for those who have had a stroke or experienced a brain injury. These implants aid in the enhancement of brain functions, such as memory, senses, and muscular motions. Brain implants are also utilized to capture and study brain activity for research purposes. These brain implants are attached to the cortex of the brain or put on the brain surface, such as over gyri and sulci. When the brain becomes dysfunctional due to numerous factors, such as head injuries or stroke, brain implants are applied. Animals with brain implants are frequently used in scientific study.

The COVID-19 pandemic outbreak had negative impact on the market. During the pandemic, the demand for brain implants were significantly less owing to the lockdown imposed by governments globally. The market is expected to recover soon as emergency lockdown is lifted by the government gradually and demand is expected to spur during the projected period.

Market Trends, Drivers, Restraints, and Opportunities

  • Rising prevalence of neurological disorders is one of the key factors driving the market growth.
  • Technological advancement in devices is expected to boost the market growth in the coming years.
  • Growing geriatric population globally is expected to increase the demand for brain implants. This is anticipated to fuel the market growth in the projected period.
  • High surgical expenses present a major challenge and is expected to hinder the market growth during the projected timeline.
  • Increasing government finance activities to raise awareness related to movement disorders is projected to create significant growth opportunities for the market in the near future.

Scope of the Report

The report on the global brain implants market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Brain Implants Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Applications (Depression, Essential Tremor, Chronic Pain, Epilepsy, Parkinson’s Disease, and Alzheimer’s Disease) and Products (Vagus Nerve Stimulator, Deep Brain Stimulator, and Spinal Cord Stimulator)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Abbott Laboratories; Medtronic plc; Aleva Neurotherapeutics SA; Boston Scientific Corp.; NeuroPace, Inc.; Nevro Corp.; and Synapse Biomedical Inc.

Market Segment Insights

Chronic pain segment to grow at a rapid pace

Based on applications, the global brain implants market is divided into depression, essential tremor, chronic pain, epilepsy, Parkinson’s disease, and Alzheimer’s disease. The chronic pain segment is expected to grow at a rapid pace during the forecast period owing to the increase in the incidence related to chronic pain, which created clinical urgency for incorporating long-term solutions. However, the Parkinson’s disease segment is anticipated to hold a key share of the market in the coming years due to the growing geriatric population, which is more susceptible to diseases like Parkinson's and Alzheimer's.

Deep brain stimulator segment to expand at a considerable CAGR

On the basis of products, the market is segregated into vagus nerve stimulator, deep brain stimulator, and spinal cord stimulator. The deep brain stimulator segment is projected to expand at a considerable CAGR during the forecast period attributed to the growing adoption for treatment of numerous neurological disorders including epilepsy, essential tremor, Parkinson’s diseases, obsessive-compulsive disorder, dystonia, and Alzheimer’s disease. On the other hand, the vagus nerve stimulator segment is anticipated to account for a major market share during the forecast period due to its application in the treatment of several disorders, such as fibromyalgia, anxiety, tinnitus, migraines, and obesity.

Brain Implants Market producsq

North America to constitute a key market share

In terms of regions, the global brain implants market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to constitute a key share of the market during the projected period owing to the factors, such as the availability of highly skilled physicians, a rise in awareness about treatments, an increase in the prevalence of neurological disorders, and the presence of well-established healthcare facilities in the region. However, the market of Asia Pacific is anticipated to expand at a rapid pace during the forecast period attributed to the need for long-term and effective treatment solutions and rising number of awareness programs across the region.

Brain Implants Market summary

Segments

Segments Covered in the Report

The global brain implants market has been segmented on the basis of

Applications

  • Depression
  • Essential Tremor
  • Chronic Pain
  • Epilepsy
  • Parkinson’s Disease
  • Alzheimer’s Disease

Products

  • Vagus Nerve Stimulator
  • Deep Brain Stimulator
  • Spinal Cord Stimulator

Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • Abbott Laboratories
  • Medtronic plc
  • Aleva Neurotherapeutics SA
  • Boston Scientific Corp.
  • NeuroPace, Inc.
  • Nevro Corp.
  • Synapse Biomedical Inc.

Competitive Landscape

Key players competing in the global brain implants market are Abbott Laboratories; Medtronic plc; Aleva Neurotherapeutics SA; Boston Scientific Corp.; NeuroPace, Inc.; Nevro Corp.; and Synapse Biomedical Inc. As part of their efforts to expand their client base and acquire a competitive advantage over competitors, manufacturers operating in the market have adopted various strategic initiatives, such as partnerships, collaborations, and mergers & acquisitions. Moreover, companies are focusing on investment in R&D for development and launching of new products to maintain their competitive positions in the market.

Brain Implants Market keyplayers

For instance, in October, 2017, NeuroPace, Inc. raised a USD 74 million funding round in support with KCK Groups and OrbiMed Advisors. The funding supported the company's efforts to expand and in commercialization of its FDA-approved DBS system, the NeuroPace RNS system. In September 2019, Abbott's Proclaim XR recharge-free SCS system for chronic pain management received FDA approval in the U. S. Low doses of electrical pulses were used in this system to assist extend the battery life of the system for up to ten years.

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. brain implants Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. brain implants Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. brain implants Market - Supply Chain
  4.5. Global brain implants Market Forecast
     4.5.1. brain implants Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. brain implants Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. brain implants Market Absolute $ Opportunity
5. Global brain implants Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. brain implants Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global brain implants Demand Share Forecast, 2019-2026
6. North America brain implants Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America brain implants Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America brain implants Demand Share Forecast, 2019-2026
7. Latin America brain implants Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America brain implants Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America brain implants Demand Share Forecast, 2019-2026
8. Europe brain implants Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe brain implants Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe brain implants Demand Share Forecast, 2019-2026
9. Asia Pacific brain implants Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific brain implants Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific brain implants Demand Share Forecast, 2019-2026
10. Middle East & Africa brain implants Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa brain implants Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa brain implants Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global brain implants Market: Market Share Analysis
  11.2. brain implants Distributors and Customers
  11.3. brain implants Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. Abbott Laboratories
     11.4.2. Medtronic plc
     11.4.3. Aleva Neurotherapeutics SA
     11.4.4. Boston Scientific Corp.
     11.4.5. NeuroPace, Inc.
     11.4.6. Nevro Corp.
     11.4.7. Synapse Biomedical Inc.

Segments Covered in the Report

The global brain implants market has been segmented on the basis of

Applications

  • Depression
  • Essential Tremor
  • Chronic Pain
  • Epilepsy
  • Parkinson’s Disease
  • Alzheimer’s Disease

Products

  • Vagus Nerve Stimulator
  • Deep Brain Stimulator
  • Spinal Cord Stimulator

Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • Abbott Laboratories
  • Medtronic plc
  • Aleva Neurotherapeutics SA
  • Boston Scientific Corp.
  • NeuroPace, Inc.
  • Nevro Corp.
  • Synapse Biomedical Inc.

Key players competing in the global brain implants market are Abbott Laboratories; Medtronic plc; Aleva Neurotherapeutics SA; Boston Scientific Corp.; NeuroPace, Inc.; Nevro Corp.; and Synapse Biomedical Inc. As part of their efforts to expand their client base and acquire a competitive advantage over competitors, manufacturers operating in the market have adopted various strategic initiatives, such as partnerships, collaborations, and mergers & acquisitions. Moreover, companies are focusing on investment in R&D for development and launching of new products to maintain their competitive positions in the market.

Brain Implants Market keyplayers

For instance, in October, 2017, NeuroPace, Inc. raised a USD 74 million funding round in support with KCK Groups and OrbiMed Advisors. The funding supported the company's efforts to expand and in commercialization of its FDA-approved DBS system, the NeuroPace RNS system. In September 2019, Abbott's Proclaim XR recharge-free SCS system for chronic pain management received FDA approval in the U. S. Low doses of electrical pulses were used in this system to assist extend the battery life of the system for up to ten years.

Buy Report